Incidence and Prevalence of Painful Diabetic Neuropathy and Postherpetic Neuralgia in Major 5 European Countries, the United States and Japan

Abstract

A547 intensity was, on average, moderate. The majority of respondents suffered pain in the head (e.g. headache and migraine) and back (e.g. lower back pain). Thirtyfour respondents (17.6%) were migraine sufferers. A third (37.3%) of respondents indicated that other family members also use CAM. The CAM classifications indicated for treating pain were cross-cultural (e.g. yoga), external (e.g. chiropractors, massage and heat therapy), internal (e.g. herbal supplements) and mind-body healing therapies (e.g. prayer therapy, sleep and meditation). The CAM modality reported to be most effective in treating pain was cross-cultural therapies with an average effectiveness of 3.6 out of a maximum score of 4.0. The most popular therapies were external body healing therapies (reported by 33.6% of respondents). Nearly half of the therapies were used in conjunction with conventional analgesics, with 43.0% indicating that they obtain their treatment for pain from pharmacies. ConClusions: CAM was used either on its own or in combination with conventional medication for the treatment of pain. Therapies seemed to be effective. The choice of CAM therapy was highly individualised.

High leukotriene B4 serum levels increase risk of painful diabetic neuropathy among type 2 diabetes mellitus patients

“…Almost 30-50% of DM patients will suffer neuropathy [4]. The prevalence of populations suffer from Painful Diabetic Neuropathy (PDN) is estimated to be 8-26% [5]. The incidence of PDN is estimated to be 17.8 per 100,000 people per year and increases with age in the United Kingdom [6].…”